glp 1 agonists and sglt2 inhibitors combination Full article: inhibitor GLP-1 receptor agonist therapy: a complementary approach to the treatment of type 2 diabetes Combination therapy with SGLT2 inhibitors
Description
Beyond the options already discussed, several compounds in early-to-mid-stage development could reshape the landscape within the next two to five years
Liver fat reduction by dose At the 1mg dose, liver fat decreased by 42.9% at 24 weeks
Fasting plasma glucose decreased by 16.2 mg/dL, compared to 9.0 mg/dL with placebo
Watch for symptoms like neck lumps, severe abdominal pain, or jaundice
